Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $740.53 | 3 | 52.4% |
| Food and Beverage | $672.34 | 40 | 47.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $740.53 | 3 | $0 (2023) |
| ABBVIE INC. | $301.33 | 20 | $0 (2024) |
| Gilead Sciences, Inc. | $98.39 | 7 | $0 (2024) |
| Braeburn Inc. | $91.83 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $60.45 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $41.95 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $23.72 | 1 | $0 (2022) |
| Indivior Inc. | $21.69 | 1 | $0 (2024) |
| Alkermes, Inc. | $17.04 | 1 | $0 (2022) |
| Axsome Therapeutics, Inc. | $15.94 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $299.16 | 20 | ABBVIE INC. ($146.25) |
| 2023 | $1,048 | 19 | Intuitive Surgical, Inc. ($740.53) |
| 2022 | $65.31 | 4 | Gilead Sciences, Inc. ($24.55) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: OUD | ||||||
| 07/31/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Opioid Use Disorder | ||||||
| 07/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: HCV | ||||||
| 04/15/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: PSYCHIATRY | ||||||
| 03/26/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Opioid Use Disorder | ||||||
| 03/14/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: PSYCHIATRY | ||||||
| 02/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Opioid Use Disorder | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.34 | General |
| 12/12/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: Neuroscience | ||||||
| 12/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Opioid Use Disorder | ||||||
| 11/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 96 | 98 | $102,944 | $8,036 |
| 2020 | 5 | 280 | 288 | $294,055 | $21,752 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 23 | 24 | $37,968 | $3,032 | 8.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 18 | 18 | $36,396 | $2,949 | 8.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 15 | 15 | $16,110 | $1,180 | 7.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 18 | 19 | $10,754 | $765.71 | 7.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 22 | 22 | $1,716 | $108.80 | 6.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 93 | 94 | $146,228 | $10,804 | 7.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 34 | 35 | $69,818 | $5,585 | 8.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 48 | 49 | $52,083 | $3,440 | 6.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 37 | 37 | $20,272 | $1,527 | 7.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 68 | 73 | $5,654 | $397.24 | 7.0% |
About Lindsey Sharp
Lindsey Sharp is a Nurse Practitioner healthcare provider based in Russellville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/19/2016. The National Provider Identifier (NPI) number assigned to this provider is 1134588015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lindsey Sharp has received a total of $1,413 in payments from pharmaceutical and medical device companies, with $299.16 received in 2024. These payments were reported across 43 transactions from 10 companies. The most common payment nature is "Travel and Lodging" ($740.53).
As a Medicare-enrolled provider, Sharp has provided services to 376 Medicare beneficiaries, totaling 386 services with total Medicare billing of $29,788. Data is available for 2 years (2020–2021), covering 10 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family
- Location Russellville, AR
- Active Since 02/19/2016
- Last Updated 04/06/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1134588015
Products in Payments
- Da Vinci Surgical System (Device) $740.53
- VRAYLAR (Drug) $269.44
- BRIXADI (Drug) $91.83
- INVEGA SUSTENNA (Drug) $60.45
- ABILIFY ASIMTUFII (Drug) $41.95
- DALVANCE (Drug) $31.89
- LOKELMA (Drug) $23.72
- SUBLOCADE (Drug) $21.69
- VIVITROL (Drug) $17.04
- Epclusa (Drug) $16.48
- Auvelity (Drug) $15.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Russellville
Melissa Corbin
Nurse Practitioner — Payments: $2,058
Natalie Hill, Anp, ANP
Nurse Practitioner — Payments: $2,033
Karen Branch, Np, NP
Nurse Practitioner — Payments: $1,249
Mrs. Bonnie Bendall, Crnp, CRNP
Nurse Practitioner — Payments: $802.15
Peggy Isaac, Cnp, CNP
Nurse Practitioner — Payments: $752.25
Jeffrey Bosold, Apn, APN
Nurse Practitioner — Payments: $638.03